Jump to content
  • 0

Advice on option expiry



0 answers to this question

Recommended Posts

There have been no answers to this question yet

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • General Statistics

    • Total Topics
    • Total Posts
    • Total Members
    • Most Online
      10/06/21 10:53

    Newest Member
    Joined 06/02/23 09:51
  • Posts

    • Hi @HenkeSeven Thanks for reaching out.  If you have not yet subscribed to the 2022/23 ISA Allowance, you have until 4 April 2023. You would need to deposit the funds £20k or less in your existing ISA account. You can continue using the same account even for the next financial years. The subscription will always be reset to £20k every financial year.  All the best,  OfentseIG
    • As earnings for the fourth quarter wind down, two stocks are worth considering, both report on Wednesday and both trade all-sessions: Disney and Uber Tech.  Jeremy Naylor | Writer, London | Publication date: Monday 06 February 2023 US earnings peak We've now passed the peak of the US earnings season for the fourth quarter (Q4). The market is still awaiting a few big numbers to come this week. And let's start first of all, with tomorrow. We've got Hertz Global. Wednesday we've got Walt Disney and Uber Technologies. Thursday, Philip Morris International. PepsiCo and Lyft. Walt Disney chart But let's take a look in some detail, a couple of those stocks I wanted to take a look at what's going on with Walt Disney, first of all, at the upcoming results to be published on Wednesday after the US markets closed. This will mark the first quarter with Bob Iger back at the helm. This is the chart for Disney. The vertical dotted line is the point at which Bob Iger came back into the business and you can see a bit of weakness following on from that. We've seen liftoff since the lows that we had back on 29 December. It has been a storming start to 2023 for the stock of Disney. And this line here, which is the high that we saw in trade last Thursday at 11360, when it reports earnings on Wednesday that the stock, if it does see some strong earnings coming through, I can easily see this area of resistance being beaten and we'll have to see what happens. Bob Iger was called back following the immediate dismissal of Bob Chapek. Iger had previously served as CEO of the group from 2005 to 2020. So far as the numbers are concerned, analysts expect earnings of $0.79 a share on revenues of $23.3 billion. Subscription numbers for Disney+, Hulu and ESPN will again be the main focus of the event I suspect. The Group's Parks and Recreation Services had a big return to growth in 2022 as people came back out after the lockdowns and markets will be looking to see whether the group managed to keep momentum going. Uber chart The other chart I think it's worth looking at is that of Uber Technologies and indeed on Friday we have seen this move up that we saw at the back end of last week, the highest intraday print since the 15th of September. And the best close that we've seen in five months for Uber technologies. Uber recorded a net loss of $1.2 billion, $512 million of which was attributable to revelations of equity investments. However, the company beat estimates for revenue, which grew by 72% year-over-year and reported adjusted EBIDTA exceeded its guidance of $440 million to $470 million. So I think that's a good reason to look positively into these numbers. As for the fourth quarter, the market expects a loss per share of $0.18 on revenues of almost $8.5 billion. The market will also be closely looking for the number of monthly active users, the number of trips and the number of customers who have subscribed to Uber 1. So some of the data points to watch out for for those two companies reporting earnings on Wednesday.
    • Tony Sycamore analyses three ASX-listed Healthcare stocks and explores if they build on recent gains.   Source: Bloomberg   Indices Shares CSL Limited Health care COVID-19 ASX  Tony Sycamore | Market Analyst, Australia | Publication date: Monday 06 February 2023  The ASX 200 added 47 points (0.67%) on Friday to close at 7558, as the ASX 200 locked in a fifth straight week (0.86%) of gains. At a sector level, gains were led by the Healthcare (+4.81%), Real Estate (+4.35%), and IT (+4.30%) sectors. At the same time, the Energy sector fell -2.14% to be back to flat on the year. Driving the Healthcare sector's outperformance, heavyweight CSL surged 6.5% to its highest weekly close in fourteen months ($314.27). Many surgeries and treatments that were delayed during Covid have resulted in long waiting lists and a solid stream of future demand for many Healthcare companies. In this week's Three Stocks to Watch, we review the recent news and charts of three ASX-listed Healthcare stocks and if they can build on recent gains. CSL (CSL) Covid is now mainly in the rear vision mirror, and aided by its acquisition of Vifor Pharma, a Swiss biotech that specialises in renal disease and iron deficiency, CSL has a bigger footprint within the industry and a more diversified earnings stream than ever before. This has resulted in broker upgrades ahead of CSL's 1H2023 earnings report on Tuesday, February 14th. As viewed on the chart below, the share price of CSL had, until late last week, spent the past three years trading in a range between $340 and $240 as Covid increased costs and reduced the number of plasma collections - an essential raw material used in many of CSL's therapies. After last week's storming run higher, CSL is eying a good layer of resistance at $320, coming from November 2021 and November 2020 highs. Should a break of this resistance occur, it would then set up a test of the February 2020 all-time high of $342.75. On the downside, should CSL fall back into the trend channel and below a layer of horizontal support $305/300, it would warn the break higher has failed and of another round of sideways price action. CSL daily chart   Source: TradingView Cochlear (COH) Cochlear, the bionic ear-making company, was another healthcare company whose product offerings were impacted during the pandemic and whose share price was range bound until late last week. Ahead of its 1H2023 earnings report on Wednesday, February 15th, the share price of Cochlear has broken above downtrend resistance to be eyeing a good band of resistance between $226 and $236 (from highs in April and August of last year). Should the share price see a sustained break above $236, it would open up a test of the $257.76 all-time high. On the downside, should the share price of COH fall back into the trend channel and below a layer of horizontal support $215/210 area, it would warn the break higher has failed and of more sideways price action in the foreseeable future. Cochlear daily chart   Source: TradingView Sonic Healthcare (SHL) Unlike the two healthcare companies above, Sonic Healthcare's earnings were boosted by the arrival of Covid, as it moved to provide tests and immunisations on top of its regular healthcare services. With Covid now mainly in the past, Covid revenues are significantly lower, and base fees have been reduced. Despite continued strong underlying demand for Sonic diagnostic health care, the share price of SHL is 32% below its $46.95 high. It appears comfortable trading in the low $30s and needing a new catalyst to reclaim ground lost over the past 12 months. Sonic Healthcare daily chart   Source: TradingView The figures stated are as of February 6th, 2023. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation. Take your position on over 13,000 local and international shares via CFDs or share trading – and trade it all seamlessly from the one account. Learn more about share CFDs or shares trading with us, or open an account to get started today.
  • Create New...